New Data Unveils Argireline® Amplified Peptide’s Ability to Extend Anti-Wrinkle Effects of Cosmetic Injections
CLEVELAND, Ohio, February 26, 2025 — Lubrizol, a global specialty chemical leader, is excited to announce the results of a groundbreaking clinical study demonstrating that the combination of Argireline® Amplified peptide and Botulinum toxin type-A (BTA) injections can keep wrinkles at bay for nearly 8 weeks longer than BTA alone. This naturally derived peptide not only…
